This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Commissariat a L'energie Atomique Et Aux Energies Alternatives, National Institute of Health and Medical Research, Université Grenoble Alpes. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Saint Etienne de Crossy, FR (2019)
- St Etienne de Crossey, FR (2022)
Company Filing History:
2 out of 8,819 
1 out of 1,853 
1 out of 178 
Years Active: 2019-2022
Title: Emmanuelle Soleilhac: Innovator in Cancer Treatment
Introduction
Emmanuelle Soleilhac is a prominent inventor based in St Etienne de Crossey, France. She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on developing novel therapeutic approaches for various cancers.
Latest Patents
One of her latest patents is titled "Heterocyclic naphthoquinones derivatives for use in the treatment of cancers including Cushing disease." This invention concerns the use of heterocyclic naphthoquinones derivatives to treat Cushing disease and other cancers, particularly through the inhibition of Ubiquitin Specific Proteases (USP) 8 and/or 2. Another significant patent is "Synthetic lethal drug combination for treating renal cell carcinoma." This invention presents a novel treatment for renal cell carcinoma and other solid tumors that harbor VHL inactivation, based on a combination of a first agent inhibiting protein kinase CK2 and a second agent inhibiting Ataxia Telangiectasia Mutated (ATM) kinase.
Career Highlights
Emmanuelle has worked with esteemed organizations such as the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and the Université d'Aix-Marseille. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Throughout her career, Emmanuelle has collaborated with notable colleagues, including Catherine Pillet and Caroline Barette. These partnerships have enriched her research and fostered innovation in her field.
Conclusion
Emmanuelle Soleilhac is a dedicated inventor whose work in cancer treatment showcases her commitment to advancing medical science. Her innovative patents and collaborations highlight her significant contributions to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile